Newer and Emerging LDL-C Lowering Agents and Implications for ASCVD Residual Risk

Multiple lines of evidence demonstrate that low-density lipoprotein-cholesterol causes atherosclerotic cardiovascular disease. Thus, targeting and lowering low-density lipoprotein-cholesterol is the principal strategy to reduce cardiovascular disease risk in primary and secondary prevention. Statin...

Descripción completa

Detalles Bibliográficos
Autores principales: Rikhi, Rishi, Shapiro, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369522/
https://www.ncbi.nlm.nih.gov/pubmed/35956226
http://dx.doi.org/10.3390/jcm11154611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369522/
https://www.ncbi.nlm.nih.gov/pubmed/35956226
http://dx.doi.org/10.3390/jcm11154611

Ejemplares similares